Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Interleukin-2 boosted immune cells but failed to preserve insulin production in the DIABIL-2 trial. Discover what this means for type 1 diabetes.
Read More »The Immune Target Moved, but the Diabetes Didn’t: What a Failed Type 1 Trial Can Teach Us
© Copyright 2026 DiabetesInControl.com, All Rights Reserved.